Status: Recruiting
The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)
This is a Prospective, multi-center study enrolling adults subjects presented to the ED/Urgent care, with symptoms consistent with lower respiratory infection (LRTI). The reason of this study is to demonstrate the MeMed BV can help clinicians make decisions about using antibiotics in patients with lower respiratory track infections and see how it would impact clinical outcomes, antibiotics use, hospitalizations, ED clinicians find ways to improve health and medical care.
Participants needed: 1,316
Trial details
Age: 18-99Biological sex: AllType: InterventionalSponsor: MeMed Diagnostics Ltd.Updated: Jan 21, 2026Locations: 10
Eligibility criteria
Written informed consent must be obtained from the patient or his/her legal guar... [+5]
Systemic antibiotics within 72 hours prior to enrollment [+10]